Class I IVD 510(k) Exemptions Should Not Have Limitations - HIMA
This article was originally published in The Gray Sheet
FDA should modify its Feb. 2 list of Class I 510(k)-exempt devices either by removing the limitations on in vitro diagnostic products or articulating the rationale for treating IVDs differently from other devices, the Health Industry Manufacturers Association says in May 4 comments to the agency.
You may also be interested in...
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.